Rivoceranib
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Rivoceranib, covering 2022-07-08 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) [Phase 2]